ProfileGDS4718 / 225079_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 95% 94% 97% 96% 94% 95% 96% 94% 96% 96% 94% 98% 95% 96% 97% 96% 97% 96% 85% 97% 97% 97% 96% 97% 96% 97% 85% 96% 95% 96% 94% 93% 96% 95% 91% 96% 96% 91% 94% 96% 98% 89% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.735896
GSM549102patient 115, normal, homogenized [OPG study]10.250195
GSM549104patient 119, normal, homogenized [OPG study]10.159694
GSM549108patient 138, normal, homogenized [OPG study]10.859497
GSM549119patient 077, normal, homogenized [OPG study]10.479596
GSM549133patient 032, cancer, homogenized [OPG study]10.10494
GSM549139patient 042, cancer, homogenized [OPG study]10.20595
GSM549099patient 107, normal, homogenized [OPG study]10.550996
GSM549109patient 139, normal, homogenized [OPG study]10.061394
GSM549110patient 046, normal, homogenized [OPG study]10.771496
GSM549114patient 063, normal, homogenized [OPG study]10.800996
GSM549122patient 082, normal, homogenized [OPG study]10.006294
GSM549134patient 033, cancer, homogenized [OPG study]11.534498
GSM549136patient 036, cancer, homogenized [OPG study]10.112795
GSM549140patient 044, cancer, homogenized [OPG study]10.495596
GSM549111patient 047, normal, homogenized [OPG study]11.135997
GSM549113patient 057, normal, homogenized [OPG study]10.781796
GSM549132patient 031, cancer, homogenized [OPG study]10.771697
GSM549137patient 038, cancer, homogenized [OPG study]10.58296
GSM549142patient 047, cancer, homogenized [OPG study]8.0949485
GSM549100patient 110, normal, homogenized [OPG study]10.99697
GSM549107patient 135, normal, homogenized [OPG study]10.897597
GSM549115patient 068, normal, homogenized [OPG study]11.037697
GSM549116patient 072, normal, homogenized [OPG study]10.585296
GSM549120patient 078, normal, homogenized [OPG study]10.967997
GSM549131patient 030, cancer, homogenized [OPG study]10.657596
GSM549118patient 074, normal, homogenized [OPG study]10.974597
GSM549129patient 027, cancer, homogenized [OPG study]8.4294785
GSM549123patient 088, normal, homogenized [OPG study]10.784796
GSM549124patient 006, cancer, homogenized [OPG study]9.9442695
GSM549126patient 015, cancer, homogenized [OPG study]10.495296
GSM549128patient 025, cancer, homogenized [OPG study]10.05594
GSM549103patient 117, normal, homogenized [OPG study]9.6137593
GSM549117patient 073, normal, homogenized [OPG study]10.701496
GSM549138patient 041, cancer, homogenized [OPG study]10.227395
GSM549141patient 045, cancer, homogenized [OPG study]9.3567891
GSM549130patient 028, cancer, homogenized [OPG study]10.322696
GSM549101patient 111, normal, homogenized [OPG study]10.343996
GSM549105patient 128, normal, homogenized [OPG study]9.2671191
GSM549106patient 134, normal, homogenized [OPG study]10.117694
GSM549112patient 048, normal, homogenized [OPG study]10.631696
GSM549125patient 011, cancer, homogenized [OPG study]11.096398
GSM549127patient 024, cancer, homogenized [OPG study]9.018389
GSM549135patient 035, cancer, homogenized [OPG study]9.542692